Diminishing accelerated long-term forgetting in mild cognitive impairment: Study protocol for a prospective, double-blind, placebo-controlled, randomized controlled trial
Background: Harnessing the lifelong potential of the human brain for neuroplasticity may serve to maintain the viability of neural structures and postpone the onset of cognitive decline. The absence of effective pharmacological interventions to counter memory decline has encouraged scientists to tes...
Main Authors: | Katherine S. Adcock, Brian Lawlor, Ian H. Robertson, Sven Vanneste |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | Contemporary Clinical Trials Communications |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451865422001065 |
Similar Items
-
Characteristics of macroscopic sleep structure in patients with mild cognitive impairment: a systematic review
by: Yahui Liang, et al.
Published: (2023-07-01) -
Subclinical naming errors in mild cognitive impairment: A semantic deficit?
by: Indra F. Willers, et al. -
Effects of Kami Guibi-tang in patients with mild cognitive impairment: study protocol for a phase III, randomized, double-blind, and placebo-controlled trial
by: Hee-Yeon Shin, et al.
Published: (2022-12-01) -
Electroencephalography-based classification of Alzheimer’s disease spectrum during computer-based cognitive testing
by: Seul-Kee Kim, et al.
Published: (2024-03-01) -
Quantitative and Qualitative Assessment of Verbal Fluency in Amnestic Mild Cognitive Impairment
by: Tuğçe Çabuk, et al.
Published: (2020-09-01)